Renewal-NAD+

nicotinamide adenine dinucleotide (NAD+) · BioNADrx Holdings, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Renewal-NAD+, covering 2026-01-13 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Renewal-NAD+: A Study of Oral NAD+ and Its Multi-omic Impact in a Healthy Cohort [EARLY_Phase 1]